Detalhe da pesquisa
1.
Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
Cytotherapy
; 16(1): 122-34, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24094498
2.
Immunothérapie adoptive antivirale après allogreffe de cellules souches hématopoïétiques.
Virologie (Montrouge)
; 16(6): 342-355, 2012 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31910553
3.
The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.
Transpl Immunol
; 24(4): 224-32, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21440066
4.
Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
Exp Hematol
; 38(5): 351-62, 2010 May.
Artigo
Inglês
| MEDLINE | ID: mdl-20172016
5.
Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy.
J Immunother
; 33(4): 414-24, 2010 May.
Artigo
Inglês
| MEDLINE | ID: mdl-20386465